Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorBiswas, S.en_US
dc.contributorDuffy, S.en_US
dc.contributorLeftkovits, J.en_US
dc.contributorAndrianopoulos, Nicken_US
dc.contributorBrennan, A.en_US
dc.contributorWalton, A.en_US
dc.contributorShaw, J.en_US
dc.contributorChan, W.en_US
dc.contributorNoaman, S.en_US
dc.contributorAjani, A.en_US
dc.contributorClark, D.en_US
dc.contributorFreeman, M.en_US
dc.contributorHiew, C.en_US
dc.contributorOqueli, Ernestoen_US
dc.contributorReid, C.en_US
dc.contributorStub, Dionen_US
dc.description.abstractBackground: Over the last decade, STEMI systems of care have evolved to improve timely access to PCI. There have also been advances in PCI technique and adjunctive pharmacotherapy. We sought to determine temporal changes in practices and clinical outcomes of PCI in STEMI patients. Method: We prospectively collected data on 8412 consecutive patients undergoing STEMI PCI between 2005 and 2016 in the multi-centre Melbourne Interventional Group registry. Data were divided by procedure year for trends analysis. The primary endpoint was 30-day mortality. Results: Patient demographics and comorbidities like smoking and diabetes have remained stable over time. The volume of primary PCI has significantly risen (65.7% to 80.1%, p < 0.01) with a concurrent fall in post-thrombolysis PCI (22.0% to 12.1%, p < 0.01). The proportion of patients achieving a door-to-balloon time ≤90 minutes has risen (37.6% to 59.0%, p < 0.01). More STEMI patients post out-of-hospital cardiac arrest or with Killip class 3-4 are now being treated with PCI. A shift from mainly femoral to radial access and from bare-metal to drug-eluting stent use was seen. Glycoprotein IIb/IIIa inhibitors are being used less frequently with increasing use of newer antiplatelet agents. Thirty-day mortality has remained low throughout the period at 6.5% overall (p for trend = 0.09). Conclusion: Despite increasing patient acuity, mortality rates have remained low for patients undergoing STEMI PCI. Timely access to primary PCI has improved likely due to better availability of 24-hour PCI and more streamlined STEMI care pathways. Preferred vascular access route, stent type and adjunctive pharmacotherapy have evolved over the last decade.en_US
dc.description.provenanceSubmitted by Gemma Siemensma ( on 2019-03-05T01:48:16Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma ( on 2019-04-05T05:49:46Z (GMT) No. of bitstreams: 0en
dc.description.provenanceMade available in DSpace on 2019-04-05T05:49:46Z (GMT). No. of bitstreams: 0 Previous issue date: 2017en
dc.titleEvolving trends in procedural characteristics and clinical Ooutcomes in patients undergoing percutaneous coronary intervention (PCI) for ST-elevation myocardial Infarction (STEMI).en_US
dc.bibliographicCitation.conferencedateAugust 10th- 13then_US
dc.bibliographicCitation.conferencename65th Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research Australasian Section Annual Scientific Meeting.en_US
dc.bibliographicCitation.conferenceplacePerth, Australiaen_US
dc.subject.healththesaurusMORTALITY RATESen_US
dc.subject.healththesaurusSTENT TYPEen_US
dc.subject.healththesaurusCARE PATHWAYSen_US
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.